clinical trial · NCT03695367
Phase 2 Herniorrhaphy Study for Opioid Elimination
Postoperative PainHTX-011Luer lock applicatorVial access deviceIbuprofenAcetaminophenKetorolac
brief summary
This is a Phase 2, open-label study in subjects undergoing unilateral open inguinal herniorrhaphy.
started
Oct 1, 2018
primary completion
Nov 20, 2018
completion
Dec 15, 2018
last updated
Mar 2, 2026
official title
A Phase 2, Open-Label Study of HTX 011 in a Multimodal Analgesic Regimen for Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol